United States · FDA National Drug Code directory
EXCEDRIN MIGRAINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0067-8201_ebe1d05e-a2d6-4092-a101-0c283ac6f95d
- Product NDC
- 0067-8201
- Form
- TABLET, FILM COATED
- Composition / generic term
- Acetaminophen, Aspirin (NSAID) and Caffeine
- Labeler
- Haleon US Holdings LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100215
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- CAFFEINE — 65 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0067-8201-03) / 300 TABLET, FILM COATED in 1 BOTTLE · 0067-8201-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →